Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05120635 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

StatusRecruiting
PhaseNot applicable
Started2021-10-01
View on ClinicalTrials.gov ↗
Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce fear and anxiety in humans. To accomplish this goal, we will measure the brain activity along with the heart rate and skin perspiration of patients while they are completing tasks on a computer. Some of the tasks will also use a virtual reality headset and transport the patient in a video game-like environment. These tasks will expose the participants to various levels of fear-provoking images. Participants with responsive neurostimulation (RNS) implants will be enrolled under Pro00117931 at Duke, but their results for fear and anxiety tasks will be reported under NCT05120635.

Amendment history 2 changes detected by DataLookout

2026-09-01
critical
Primary completion pushed: 2026-06-30 → 2027-05-31
2026-09-01
minor
Completion pushed: 2026-06-30 → 2027-05-31
Trial Details
NCT Number NCT05120635
Lead Sponsor Duke University
Collaborators: National Institutes of Health (NIH), VA Greater Los Angeles Healthcare System, NeuroPace, National Institute of Mental Health (NIMH)
Conditions Fear, GAD, Emotional Memory, PTSD
Enrollment 80 participants
Start Date 2021-10-01
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-31